Geron Corporation (GERN) Increases Stake in TA Therapeutics, Limited Joint Venture  
6/18/2007 1:18:10 PM

MENLO PARK, Calif. & HONG KONG--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN) and the Biotechnology Research Corporation (BRC) of Hong Kong today announced that Geron has increased its stake in their joint venture entity, TA Therapeutics Limited (TAT), from 50% ownership to 75% ownership.